...

首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?

【24h】

Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?

机译：可以将流出基质金属蛋白酶2和纤溶酶原激活物抑制剂1用作腹膜透析患者腹膜膜改变的生物标志物吗？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis》 |2013年第5期|共页
作者
Annemieke M. Coester; Deirisa Lopes Barreto; Dirk G. Struijk; Raymond T. Krediet;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? [J] . BarretoD.L., CoesterA.M., StruijkD.G., Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2013,第5期

机译：可以将流出基质金属蛋白酶2和纤溶酶原激活物抑制剂1用作腹膜透析患者腹膜改变的生物标志物吗？
2. MicroRNAs in peritoneal dialysis effluent are promising biomarkers for peritoneal fibrosis in peritoneal dialysis patients [J] . GeY., XiaoL., ChenX., Medical hypotheses . 2012,第1期

机译：腹膜透析流出物中的MicroRNA是腹膜透析患者腹膜纤维化的有前途的生物标志物
3. Matrix metalloproteinase levels in peritoneal effluents were increased in a patient with appendicitis undergoing continuous ambulatory peritoneal dialysis [J] . TakezawaY., SaitouY., UchidaT., Clinical and experimental nephrology . 2012,第3期

机译：进行连续非卧床腹膜透析的阑尾炎患者腹膜流出物中的基质金属蛋白酶水平升高
4. Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis [C] . Takehito Kobayashi, Toru Noguchi, Kohei Saito, Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai . 2018

机译：腹膜纤维化患者嗜酸性炎症患者接受腹膜透析
5. Quality of Life of Peritoneal Dialysis and Hemodialysis Patients: A Pilot Comparative Study. [D] . Vigil, Anna. 2019

机译：腹膜透析和血液透析患者的生活质量：试点比较研究。
6. Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients? [O] . Deirisa Lopes Barreto, Annemieke M. Coester, Dirk G. Struijk, 2013

机译：流出基质金属蛋白酶2和纤溶酶原激活物抑制剂1可以用作腹膜透析患者腹膜膜改变的生物标志物吗？
7. Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? [O] . Barreto, Deirisa Lopes, Coester, Annemieke M., Struijk, Dirk G., 2013

机译：流出液基质金属蛋白酶2和纤溶酶原激活物抑制剂1可以用作腹膜透析患者腹膜改变的生物标志物吗？
8. Investigation of the Risks and Hazards with Devices Associated with Peritoneal Dialysis (Including Intermittent Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis) and Sorbent Regenerated Dialysate Delivery Systems [R] . Ward, R. A. 1982

机译：腹膜透析（包括间歇性腹膜透析和持续性非卧床腹膜透析）和吸附剂再生透析液输送系统相关设备的风险和危害调查

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号